Clinical TrialID 6659
Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
NCT00498979
Stage IV Melanoma
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6659
- Evidence Id
- 6659
- Core Evidence Id
- 6659
- Source Clinical Trial Id
- 6645
- Herb2 Clinical Trial Id
- HBCT006645
- Nct Id
- NCT00498979
- Title
- Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Stage IV Melanoma
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- BIOLOGICAL: recombinant interferon alfa-2b|DRUG: cisplatin|DRUG: sodium stibogluconate|DRUG: dacarbazine|DRUG: vinblastine
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 22
- Outcome Measure
- Safety of the combination of sodium stibogluconate and interferon alfa-2b with chemotherapy, 2 years
- Sponsor Collaborator
- Case Comprehensive Cancer Center|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States
- Other Id
- CASE3Y06
- Start Date
- 2007-05
- Primary Completion Date
- 2010-05
- Completion Date
- 2012-01
- First Posted
- 2007-07-11
- Results First Posted
- Last Update Posted
- 2020-07-24
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00498979
- Title Cn
- Title En
- Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
- Bilingual Status
- semi_complete